Columbia Pipeline Group, Inc.
CPGX News Today: Stay Updated with the Latest Columbia Pipeline Group, Inc. News in Real Time
Find CPGX news now at Meyka AI. Stay informed with the latest Columbia Pipeline Group, Inc. stocks updates, including price news, market analysis, and expert insights.
Coforge Limited Surges 10.1% on Strong AI and Digital Services Demand
COFORGE.NS stock jumps 10.1% to ₹1,412 on strong earnings and digital transformation demand. IT services leader gains momentum.
UK Stock Market Rally FTSE 100 Hits 10,403.74 Up 0.77% FTSE 250 Climbs 22,809.77 as IG Group, Diploma and Airtel Africa Surge
The Stock Market in the United Kingdom recorded a strong rally as major indices posted solid gains in recent trading sessions. The FTSE 100 rose 0.77 percent to close at 10,403.74, while the FTSE 250 advanced to 22,809.77, reflecting broad based investor optimism. The upward movement was driven by strong earnings updates, improving global sentiment,…
How to Use Proxy with ChatGPT
Modern engineering teams rarely treat the OpenAI API as a stand-alone endpoint. It sits inside larger pipelines, alongside scrapers, classifiers, vector databases, and queues, and every pipeline of that scale needs deterministic control over outbound traffic. That control is what a proxy provides. Understanding how to use a proxy with ChatGPT correctly is the difference…
Quest PharmaTech Inc. (QPTFF) Surges 128.6% in Six Months on Cancer Therapy Pipeline
QPTFF stock analysis: Quest PharmaTech rises 128.6% over six months with lead cancer immunotherapy candidate advancing clinical trials.
Starcoin Group Limited Surges 32.7% on Heavy Trading Volume
0399.HK stock jumps 32.7% to HK$0.073 on record trading volume of 175M shares. Meyka AI rates the stock B-grade.
Blockchain Venture Capital Inc. Tumbles 32% as BVCI.CN Faces Profitability Headwinds
BVCI.CN stock crashes 32% to C$0.20. Toronto-based blockchain firm struggles with negative earnings and weak cash flow metrics.
Sunshine Biopharma Surges 79.5% on $6 Million Public Offering
SBFM stock jumps 79.5% as Sunshine Biopharma prices $6 million public offering at $0.50 per unit in pre-market trading.
XRAY: Director Mazelsky Acquires 2,638 Phantom Stock Shares May 19, 2026
DENTSPLY SIRONA director Jonathan Mazelsky acquired 2,638 phantom stock shares via deferred compensation award on Dec 31, 2025.
FBIO: Citigroup Maintains Buy Rating, May 2026
Citigroup maintains Buy rating on Fortress Biotech (FBIO) with price target raised to $5 from $4.50 at Alliance Global.